RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
130 hedge funds and large institutions have $732M invested in Revance Therapeutics, Inc. in 2020 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 52 increasing their positions, 38 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
3% less funds holding
Funds holding: 134 → 130 (-4)
12% less capital invested
Capital invested by funds: $828M → $732M (-$96.2M)
Holders
130
Holding in Top 10
2
Calls
$1.66M
Puts
$869K
Top Buyers
| 1 | +$25.2M | |
| 2 | +$9.23M | |
| 3 | +$7.8M | |
| 4 |
BlackRock
New York
|
+$4.72M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$3.87M |
Top Sellers
| 1 | -$15.5M | |
| 2 | -$14.6M | |
| 3 | -$14.2M | |
| 4 |
PC
Polar Capital
London,
United Kingdom
|
-$10.7M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$6.46M |